CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 583.63M
Enterprise Value 379.14M
Trailing P/E N/A
Forward P/E 111.10
PEG Ratio (5 yr expected) 10.46
Price/Sales (ttm)1.84
Price/Book (mrq)1.56
Enterprise Value/Revenue 31.74
Enterprise Value/EBITDA 6-72.89

Trading Information

Stock Price History

Beta (3Y Monthly) -0.19
52-Week Change 3-2.52%
S&P500 52-Week Change 32.33%
52 Week High 37.00
52 Week Low 34.83
50-Day Moving Average 35.85
200-Day Moving Average 35.92

Share Statistics

Avg Vol (3 month) 324.78k
Avg Vol (10 day) 312.62k
Shares Outstanding 515.54M
Float 8.03M
% Held by Insiders 142.13%
% Held by Institutions 132.52%
Shares Short (Jul 31, 2019) 483.23k
Short Ratio (Jul 31, 2019) 42.54
Short % of Float (Jul 31, 2019) 40.92%
Short % of Shares Outstanding (Jul 31, 2019) 40.54%
Shares Short (prior month Jun 28, 2019) 494.37k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jul 6, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -9.87%
Operating Margin (ttm)-10.66%

Management Effectiveness

Return on Assets (ttm)-3.06%
Return on Equity (ttm)-7.95%

Income Statement

Revenue (ttm)45.47M
Revenue Per Share (ttm)2.93
Quarterly Revenue Growth (yoy)13.90%
Gross Profit (ttm)33.36M
EBITDA -1.09M
Net Income Avi to Common (ttm)-4.49M
Diluted EPS (ttm)-0.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.43M
Total Cash Per Share (mrq)1.98
Total Debt (mrq)23.4M
Total Debt/Equity (mrq)43.59
Current Ratio (mrq)2.33
Book Value Per Share (mrq)3.49

Cash Flow Statement

Operating Cash Flow (ttm)3.55M
Levered Free Cash Flow (ttm)-2.99M